3020B |
Methylphenidate and Metabolite, Blood |
3020SP |
Methylphenidate and Metabolite, Serum/Plasma |
3020TI |
Methylphenidate and Metabolite, Tissue |
3020U |
Methylphenidate and Metabolite, Urine |
3045B |
Modafinil / Armodafinil, Blood |
3045SP |
Modafinil / Armodafinil, Serum/Plasma |
3150B |
Nicotine and Metabolite, Blood |
3150FL |
Nicotine and Metabolite, Fluid |
3150SP |
Nicotine and Metabolite, Serum/Plasma |
3150TI |
Nicotine and Metabolite, Tissue |
3150U |
Nicotine and Metabolite with Anabasine, Urine |
3426B |
Perfluorooctanoic Acid, Blood Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3427SP |
Perfluoroalkyl Substances (PFAS), Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3428SP |
PFASure TM, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3429SP |
PFASure TM Expanded, Serum/Plasma Overview: Monitoring for exposure to Per- and Polyfluorinated alkyl substances |
3690B |
Phentermine, Blood |
3690SP |
Phentermine, Serum/Plasma |
3690U |
Phentermine, Urine |
3752B |
Phosphatidylethanol, Blood |
3975B |
Propanol, n-, Blood |
3975SP |
Propanol, n-, Serum/Plasma |
3975U |
Propanol, n-, Urine |